drugset / Trial / NCT03991169
Oral Iron in Children With Chronic Kidney Disease
Phase 4
Recruiting
40 enrolled
Weill Medical College of Cornell University
Children's Hospital of Philadelphia · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and changes in eating behavior, which will be measured at enrollment and at the end of the study period.
Timeline
- Start
- 2019-04-19
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 3 mg/kg | Oral |
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 6 mg/kg | Oral |
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 325 mg | Oral |